Impact of Soy Foods on the Development of Breast Cancer and the Prognosis of Breast Cancer Patients

Forschende Komplementarmedizin

Volumn 23, Issue 2, 2016, Pages 75-80

  Messina, Mark ^a  

^a Nutrition Matters Inc   (United States)

Author keywords

Breast cancer; Isoflavones; Patients; Prevention; Soy foods; Summary

Indexed keywords

ISOFLAVONE DERIVATIVE;

ADOLESCENT; ADULT; AGE; BREAST NEOPLASMS; CHILD; DIET THERAPY; FEMALE; HUMAN; PROGNOSIS; RISK; SOY FOOD; UNITED STATES; VEGETARIAN DIET;

ADOLESCENT; ADULT; AGE FACTORS; BREAST NEOPLASMS; CHILD; DIET, VEGETARIAN; FEMALE; HUMANS; ISOFLAVONES; PROGNOSIS; RISK; SOY FOODS; UNITED STATES;

EID: 84963623268     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000444735     Document Type: Review

References (87)

1. Barnes S, Grubbs C, Setchell KD, Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 1990; 347: 239-253.
2. Pisani P, Parkin DM, Bray F, Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
3. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592-5595.
4. Messina M, Barnes S: The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991; 83: 541-546.
5. Franke AA, Custer LJ, Wang W, Shi CY: HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 1998; 217: 263-273.
6. Russo M, Russo GL, Daglia M, Kasi PD, Ravi S, et al: Understanding genistein in cancer: The 'good' and the 'bad' effects: A review. Food Chem 2016; 196: 589-600.
7. Sarkar FH, Li Y: Soy isoflavones and cancer prevention. Cancer Invest 2003; 21: 744-757.
8. Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M: Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause 2012; 19: 776-790.
9. Li SH, Liu XX, Bai YY, Wang XJ, Sun K, et al: Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a metaanalysis of randomized placebo-controlled trials. Am J Clin Nutr 2010; 91: 480-486.
10. Jenkins G, Wainwright LJ, Holland R, Barrett KE, Casey J: Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomised study. Int J Cosmet Sci 2013; 36: 22-31.
11. Pawlowski JW, Martin BR, McCabe GP, McCabe L, Jackson GS, et al: Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial. Am J Clin Nutr 2015; 102: 695-703.
12. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG: Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 2001; 61: 5045-5050.
13. Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG: Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 2006; 27: 856-863.
14. Messina M: Post-diagnosis soy isoflavone intake is not harmful to women with breast cancer. Breast Diseases: A Year Book Quarterly 2015; 26: 193-197.
15. Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG: Postdiagnosis soy food intake and breast cancer survival: A meta-analysis of cohort studies. Asian Pac J Cancer Prev 2013; 14: 2407-2412.
16. Messina M, Nagata C, Wu AH: Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006; 55: 1-12.
17. Bai W, Wang C, Ren C: Intakes of total and individual flavonoids by US adults. Int J Food Sci Nutr 2014; 65: 9-20.
18. Zamora-Ros R, Knaze V, Lujan-Barroso L, Kuhnle GG, Mulligan AA, et al: Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr 2012; 66: 932-941.
19. Rizzo NS, Jaceldo-Siegl K, Sabate J, Fraser GE: Nutrient profiles of vegetarian and nonvegetarian dietary patterns. J Acad Nutr Diet 2013; 113: 1610-1619.
20. Oseni T, Patel R, Pyle J, Jordan VC: Selective estrogen receptor modulators and phytoestrogens. Planta Med 2008; 74: 1656-1665.
21. Sareddy GR, Vadlamudi RK: Cancer therapy using natural ligands that target estrogen receptor beta. Chin J Nat Med 2015; 13: 801-807.
22. Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MR, Hanby AM: Oestrogen receptor beta: what it means for patients with breast cancer. Lancet Oncol 2004; 5: 174-181.
23. Alekel DL, Van Loan MD, Koehler KJ, Hanson LN, Stewart JW, et al: The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women. Am J Clin Nutr 2010; 91: 218-230.
24. Sampey BP, Lewis TD, Barbier CS, Makowski L, Kaufman DG: Genistein effects on stromal cells determines epithelial proliferation in endometrial co-cultures. Exp Mol Pathol 2011; 90: 257-263.
25. Murray MJ, Meyer WR, Lessey BA, Oi RH, DeWire RE, Fritz MA: Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial. Menopause 2003; 10: 456-464.
26. Kayisli UA, Aksu CA, Berkkanoglu M, Arici A: Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab 2002; 87: 5539-5544.
27. Thomas P, Dong J: Binding and activation of the seventransmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol 2006; 102: 175-179.
28. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, et al: The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004; 279: 27008-27016.
29. Murphy PA, Barua K, Hauck CC: Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777: 129-138.
30. Song TT, Hendrich S, Murphy PA: Estrogenic activity of glycitein, a soy isoflavone. J Agric Food Chem 1999; 47: 1607-1610.
31. Messina M: Western soy intake is too low to produce health effects. Am J Clin Nutr 2004; 80: 528-529.
32. Chen M, Rao Y, Zheng Y, Wei S, Li Y, et al: Association between soy isoflavone intake and breast cancer risk for pre-and post-menopausal women: a meta-analysis of epidemiological studies. PLoS One 2014; 9:e89288.
33. Hooper L, Madhavan G, Tice JA, Leinster SJ, Cassidy A: Effects of isoflavones on breast density in pre-and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update 2010; 16: 745-760.
34. Wu AH, Spicer D, Garcia A, Tseng CC, Hovanessian-Larsen L, et al: Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density. Cancer Prev Res (Phila) 2015; 8: 942-951.
35. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, et al: Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999; 84: 4017-4024.
36. Sartippour MR, Rao JY, Apple S, Wu D, Henning S, et al: A pilot clinical study of short-term isoflavone supplements in breast cancer patients. Nutr Cancer 2004; 49: 59-65.
37. Palomares MR, Hopper L, Goldstein L, Lehman CD, Storer BE, Gralow JR: Effect of soy isoflavones on breast proliferation in postmenopausal breast cancer survivors. Breast Cancer Res Treatment 2004; 88(Suppl 1):abstr 4002.
38. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM: Isoflavone treatment for acute menopausal symptoms. Menopause 2007; 14: 468-473.
39. Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, et al: Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase II trial. Cancer Prev Res (Phila) 2012; 5: 309-319.
40. Shike M, Doane AS, Russo L, Cabal R, Reis-Filo J, et al: The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study. J Natl Cancer Inst 2014; 106:dju189.
41. Messina M, Hilakivi-Clarke L: Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer 2009; 61: 792-798.
42. Messina M, Wu AH: Perspectives on the soy-breast cancer relation. Am J Clin Nutr 2009; 89: 1673S-1679S.
43. Mikkila V, Rasanen L, Raitakari OT, Pietinen P, Viikari J: Consistent dietary patterns identified from childhood to adulthood: the cardiovascular risk in Young Finns Study. Br J Nutr 2005; 93: 923-931.
44. Lamartiniere CA, Moore J, Holland M, Barnes S: Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 1995; 208: 120-123.
45. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S: Genistein suppresses mammary cancer in rats. Carcinogenesis 1995; 16: 2833-2840.
46. Lamartiniere CA, Zhao YX, Fritz WA: Genistein: mammary cancer chemoprevention, in vivo mechanisms of action, potential for toxicity and bioavailability in rats. J Women's Cancer 2000; 2: 11-19.
47. Korde LA, Wu AH, Fears T, Nomura AM, West DW, et al: Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 2009; 18: 1050-1059.
48. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC: Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002; 23: 1491-1496.
49. Shu XO, Jin F, Dai Q, Wen W, Potter JD, et al: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 483-488.
50. Lee SA, Shu XO, Li H, Yang G, Cai H, et al: Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr 2009; 89: 1920-1926.
51. Travis RC, Allen NE, Appleby PN, Spencer EA, Roddam AW, Key TJ: A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int J Cancer 2008; 122: 705-710.
52. Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH: Breast differentiation and its implication in cancer prevention. Clin Cancer Res 2005; 11: 931s-936s.
53. Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, et al: The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis 2010; 31: 886-893.
54. de Assis S, Warri A, Benitez C, Helferich W, Hilakivi-Clarke L: Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. Cancer Prev Res (Phila) 2011; 4: 1436-1448.
55. Rahal OM, Simmen RC: Paracrine-acting adiponectin promotes mammary epithelial differentiation and synergizes with genistein to enhance transcriptional response to estrogen receptor beta signaling. Endocrinology 2011; 152: 3409-3421.
56. Mishra P, Kar A, Kale RK: Prepubertal daidzein exposure enhances mammary gland differentiation and regulates the expression of estrogen receptor-alpha and apoptotic proteins. ISRN Oncol 2011; 2011: 896826.
57. Potischman N, Linet MS: Invited commentary: are dietary intakes and other exposures in childhood and adolescence important for adult cancers? Am J Epidemiol 2013; 178: 184-189.
58. Meier-Abt F, Bentires-Alj M: How pregnancy at early age protects against breast cancer. Trends Mol Med 2014; 20: 143-153.
59. Hughes GJ, Ryan DJ, Mukherjea R, Schasteen CS: Protein digestibility-corrected amino acid scores (PDCAAS) for soy protein isolates and concentrate: Criteria for evaluation. J Agric Food Chem 2011; 59: 12707-12712.
60. Slavin M, Kenworthy W, Yu LL: Antioxidant properties, phytochemical composition, and antiproliferative activity of Maryland-grown soybeans with colored seed coats. J Agric Food Chem 2009; 57: 11174-11185.
61. Carmignani LO, Pedro AO, Costa-Paiva LH, Pinto-Neto AM: The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas 2010; 67: 262-269.
62. Cheng WC, Lo SC, Tsai KS, Tu ST, Wu JS, et al: Effects of high-dose phytoestrogens on circulating cellular microparticles and coagulation function in postmenopausal women. J Formos Med Assoc 2015; 114: 710-716.
63. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, et al: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013; 310: 1353-1368.
64. Chlebowski RT, Anderson GL: Changing concepts: Menopausal hormone therapy and breast cancer. J Natl Cancer Inst 2012; 104: 517-527.
65. Setchell KD, Brown NM, Zhao X, Lindley SL, Heubi JE, et al: Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr 2011; 94: 1284-1294.
66. Onoda A, Ueno T, Uchiyama S, Hayashi S, Kato K, Wake N: Effects of S-equol and natural S-equol supplement (SE5-OH) on the growth of MCF-7 in vitro and as tumors implanted into ovariectomized athymic mice. Food Chem Toxicol 2011; 49: 2279-2284.
67. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, et al: Soy food intake and breast cancer survival. JAMA 2009; 302: 2437-2443.
68. Caan BJ, Natarajan L, Parker B, Gold EB, Thomson C, et al: Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 2011; 20: 854-858.
69. Guha N, Kwan ML, Quesenberry CP, Jr., Weltzien EK, Castillo AL, Caan BJ: Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat 2009; 118: 395-405.
70. Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, et al: Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr 2012; 96: 123-132.
71. Kang X, Zhang Q, Wang S, Huang X, Jin S: Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ 2010; 182: 1857-1862.
72. Zhang YF, Kang HB, Li BL, Zhang RM: Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev 2012; 13: 479-482.
73. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG: Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 2002; 62: 2474-2477.
74. Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG: Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 2008; 29: 2162-2168.
75. Kang X, Jin S, Zhang Q: Antitumor and antiangiogenic activity of soy phytoestrogen on 7,12-dimethylbenz [alpha]anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats. J Food Sci 2009; 74:H237-242.
76. Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J: Soy and breast cancer: Focus on angiogenesis. Int J Mol Med 2015; 16: 11728-11749.
77. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, et al: Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 2008; 68: 2024-2032.
78. Xiao X, Liu Z, Wang R, Wang J, Zhang S, et al: Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis. Oncotarget 2015; 6: 3225-3239.
79. Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, et al: MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 2009; 101: 1141-1155.
80. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, et al: Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab 2008; 93: 4787-4796.
81. Dorjgochoo T, Gu K, Zheng Y, Kallianpur A, Chen Z, et al: Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis. Breast Cancer Res Treat 2011; 130: 879-889.
82. EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food): Scientific opinion on the risk assessment for peri-and post-menopausal women taking food supplements containing isolated isoflavones. EFSA J 2015; 13: 4246.
83. Gonzales JF, Barnard ND, Jenkins DJ, Lanou AJ, Davis B, et al: Applying the precautionary principle to nutrition and cancer. J Am Coll Nutr 2014; 33: 239-246.
84. Segovia-Siapco G, Pribis P, Messina M, Oda K, Sabate J: Is soy intake related to age at onset of menarche? A cross-sectional study among adolescents with a wide range of soy food consumption. Nutr J 2014; 13: 54.
85. Wang J, Betancourt A, Jenkins S, Biro F, Pinney SM, et al: Altered blood proteome in girls with high urine concentrations of bisphenol A, genistein, mono-ethyl hexylphthalate and mono-benzyl phthalate. MOJ Proteomics Bioinform 2015; 2: 00040.
86. Betancourt AM, Wang J, Jenkins S, Mobley J, Russo J, Lamartiniere CA: Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol A and genistein. J Nutr 2012; 142: 1382S-1388S.
87. Jenkins S, Betancourt AM, Wang J, Lamartiniere CA: Endocrine-active chemicals in mammary cancer causation and prevention. J Steroid Biochem Mol Biol 2012; 129: 191-200.